Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: The superiority of fluorescence in situ hybridization over ERG immunohistochemistry

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2227-2233

  Schelling, Lindsay A ^a   Williamson, Sean R ^a   Zhang, Shaobo ^a   Yao, Jorge L ^b   Wang, Mingsheng ^a   Huang, Jiaoti ^c   Montironi, Rodolfo ^d   Lopez Beltran, Antonio ^e   Emerson, Robert E ^a   Idrees, Muhammad T ^a   Osunkoya, Adeboye O ^f   Man, Yan Gao ^g   Maclennan, Gregory T ^h   Baldridge, Lee Ann ^a   Compérat, Eva ⁱ   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e UNIVERSITY OF CÓRDOBA   (Spain)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Nanjing Cardiovascular Hospital   (China)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Fluorescence in situ hybridization; Histogenesis Neuroendocrine tumor; Molecular genetics; Prostate; Small cell carcinoma; TMPRSS2 ERG rearrangement; Tumor of unknown origin

Indexed keywords

MEMBRANE PROTEIN; TRANSCRIPTION FACTOR ERG; TRANSMEMBRANE PROTEASE SERINE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROSTATE CARCINOMA; SMALL CELL CARCINOMA;

FLUORESCENCE IN SITU HYBRIDIZATION; HISTOGENESIS; MOLECULAR GENETICS; NEUROENDOCRINE TUMOR; PROSTATE; SMALL CELL CARCINOMA; TMPRSS2-ERG REARRANGEMENT; TUMOR OF UNKNOWN ORIGIN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROSTATIC NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884418404     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.05.005     Document Type: Article

References (34)

1. W. Wang, and J.I. Epstein Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases Am J Surg Pathol 32 2008 65 71
2. J.L. Yao, R. Madeb, and P. Bourne Small cell carcinoma of the prostate: an immunohistochemical study Am J Surg Pathol 30 2006 705 712
3. S.R. Williamson, S. Zhang, and J.L. Yao ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin Mod Pathol 24 2011 1120 1127
4. J.R. Mackey, H.J. Au, J. Hugh, and P. Venner Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival J Urol 159 1998 1624 1629
5. S.A. Nicholson, M.B. Beasley, and E. Brambilla Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens Am J Surg Pathol 26 2002 1184 1197
6. A.M. Quinn, F. Blackhall, and G. Wilson Extrapulmonary small cell carcinoma: a clinicopathological study with identification of potential diagnostic mimics Histopathology 61 2012 454 464
7. B. Han, R. Mehra, and K. Suleman Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma Mod Pathol 22 2009 1176 1185
8. C.C. Guo, J.Y. Dancer, and Y. Wang TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate Hum Pathol 42 2011 11 17
9. S.M. Falzarano, M. Navas, and K. Simmerman ERG rearrangement is present in a subset of transition zone prostatic tumors Mod Pathol 23 2010 1499 1506
10. S.A. Tomlins, A. Bjartell, and A.M. Chinnaiyan ETS gene fusions in prostate cancer: from discovery to daily clinical practice Eur Urol 56 2009 275 286
11. R.B. Shah Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management Adv Anat Pathol 20 2013 117 124
12. V.J. Scheble, M. Braun, and R. Beroukhim ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor Mod Pathol 23 2010 1061 1067
13. T.L. Lotan, N.S. Gupta, and W. Wang ERG gene rearrangements are common in prostatic small cell carcinomas Mod Pathol 24 2011 820 828
14. K. Park, S.A. Tomlins, and K.M. Mudaliar Antibody-based detection of ERG rearrangement-positive prostate cancer Neoplasia 12 2010 590 598
15. S. Perner, J.M. Mosquera, and F. Demichelis TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion Am J Surg Pathol 31 2007 882 888
16. B. Furusato, C.L. Gao, and L. Ravindranath Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer Mod Pathol 21 2008 67 75
17. C.C. Guo, Y. Wang, L. Xiao, P. Troncoso, and B.A. Czerniak The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers Hum Pathol 43 2012 644 649
18. D.G. Bostwick, and L. Cheng Urologic Surgical Pathology Ed 3 2014 Elsevier Philadelphia, PA
19. R. Esgueva, S. Perner, and C. LaFargue Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort Mod Pathol 23 2010 539 546
20. R. Mehra, S.A. Tomlins, and R. Shen Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer Mod Pathol 20 2007 538 544
21. B. Han, R. Mehra, and R.J. Lonigro Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression Mod Pathol 22 2009 1083 1093
22. B. Furusato, S.H. Tan, and D. Young ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification Prostate Cancer Prostatic Dis 13 2010 228 237
23. G.J. van Leenders, J.L. Boormans, and C.J. Vissers Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice Mod Pathol 24 2011 1128 1138
24. M. Braun, D. Goltz, and Z. Shaikhibrahim ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer-a comparative study of two monoclonal antibodies Prostate Cancer Prostatic Dis 15 2012 165 169
25. H. Beltran, D.S. Rickman, and K. Park Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets Cancer Discov 1 2011 487 495
26. K.G. Hermans, R. van Marion, H. van Dekken, G. Jenster, W.M. van Weerden, and J. Trapman TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer Cancer Res 66 2006 10658 10663
27. J. Yu, R.S. Mani, and Q. Cao An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression Cancer Cell 17 2010 443 454
28. C. Cai, H. Wang, and H.H. He ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer J Clin Invest 123 2013 1109 1122
29. L. Yin, P. Rao, P. Elson, J. Wang, M. Ittmann, and W.D. Heston Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression PLoS One 6 2011 e21319
30. J.M. Mosquera, H. Beltran, and K. Park Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer Neoplasia 15 2013 1 10
31. R. Mehra, S.A. Tomlins, and J. Yu Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer Cancer Res 68 2008 3584 3590
32. G. Attard, J. Clark, and L. Ambroisine Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer Oncogene 27 2008 253 263
33. M. Miettinen, Z.F. Wang, and A. Paetau ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma Am J Surg Pathol 35 2011 432 441
34. P. Mhawech-Fauceglia, F.R. Herrmann, and W. Bshara Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody J Clin Pathol 60 2007 694 700